Why South Africa stopped making vaccines

“The current procurement mechanism is counterproductive to attracting investors or safeguarding existing investments. A company might invest massively to scale up its production to meet one particular contract, but two years later, you could lose the entirety of it if the contract changes and you have two years of nothing, then later you might have to upscale again.”

via Bhekisisa Centre for Health Journalism
More analysis from COVID-19 Africa Watch: